QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease
- Status
- COMPLETED
- Phase
- NA
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
- Status
- UNKNOWN
- Phase
- N/A
Cardiovascular Effects of CART Cell Therapy
- Status
- COMPLETED
- Phase
- N/A
ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas
- Status
- UNKNOWN
- Phase
- PHASE1
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE2
CMP-001 for Relapsed and Refractory Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT
- Status
- UNKNOWN
- Phase
- PHASE2
The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Diffusion-weighted Magnetic Resonance Imaging in Post Therapy Patients With Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Effect of Vitamin C in Autologous Stem Cell Transplantations
- Status
- COMPLETED
- Phase
- PHASE2
Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
- Status
- COMPLETED
- Phase
- PHASE3
HeartPhone Cancer Survivors Trial 2019
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2